Oh my...that post. Why waste your time LH.
The impact of today’s announcement may not have been truely understood just how important it is, but over the next little period this will be pivotal to supporting the other part to OBJ’s strategy in my opinion. Having this in place sures up the revenue structure and will enable the board to finalise plans for BG and how this will be funded.
If BG is successful I think $2-3m revenue per quarter will be very easily achieved in addition to the $1-2m royalties that coincide.
- Forums
- ASX - By Stock
- WFL
- Ann: Term Sheet Executed for First Integrated Product
Ann: Term Sheet Executed for First Integrated Product, page-31
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online